Transparency Guidelines
Disclosing Information Regarding
Transparency in the Relationship between Corporate Activities and Medical Institutions
Purpose of Disclosure
DENIS PHARMA K.K., as a member of the Japan Association of Clinical Reagents Industries (JACRI), has established the “Transparency Guideline for the Relationship between Corporate Activities and Medical Institutions” to ensure transparency in all activities conducted with medical institutions, in accordance with the principles of the “Code of Ethical Practice for In Vitro Diagnostics” and the “Promotion Code for In Vitro Diagnostics” established by JACRI, as well as other related rules and guidelines. Based on this guideline, DENIS PHARMA discloses relevant information on its corporate website.